These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 10445667

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition.
    Kaikita K, Fogo AB, Ma L, Schoenhard JA, Brown NJ, Vaughan DE.
    Circulation; 2001 Aug 14; 104(7):839-44. PubMed ID: 11502712
    [Abstract] [Full Text] [Related]

  • 24. Chronic inhibition of nitric-oxide synthase induces hypertension and erectile dysfunction in the rat that is not reversed by sildenafil.
    Gur S, Kadowitz PJ, Gurkan L, Chandra S, Dewitt SY, Harbin A, Sikka SC, Agrawal KC, Hellstrom WJ.
    BJU Int; 2010 Jul 14; 106(1):78-83. PubMed ID: 20002674
    [Abstract] [Full Text] [Related]

  • 25. Nitric oxide synthase inhibition with N omega-nitro-L-arginine methyl ester affects blood pressure and cardiovascular structure in the genetically hypertensive rat strain.
    Ledingham JM, Laverty R.
    Clin Exp Pharmacol Physiol; 1997 Jun 14; 24(6):433-5. PubMed ID: 9171951
    [Abstract] [Full Text] [Related]

  • 26. Malignant alterations following early blockade of nitric oxide synthase in hypertensive rats.
    Hsu YH, Hsu BG, Chen HI.
    Chin J Physiol; 2007 Dec 31; 50(6):283-93. PubMed ID: 18442011
    [Abstract] [Full Text] [Related]

  • 27. Long-acting Ca2+ blockers prevent myocardial remodeling induced by chronic NO inhibition in rats.
    Sanada S, Node K, Minamino T, Takashima S, Ogai A, Asanuma H, Ogita H, Liao Y, Asakura M, Kim J, Hori M, Kitakaze M.
    Hypertension; 2003 Apr 31; 41(4):963-7. PubMed ID: 12629037
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. L-NAME treatment enhances exercise-induced content of myocardial heat shock protein 72 (Hsp72) in rats.
    Lunz W, Capettini LS, Davel AP, Munhoz CD, da Silva JF, Rossoni LV, Lemos VS, Baldo MP, Carneiro-Junior MA, Natali AJ, de Lacerda LH, Mill JG.
    Cell Physiol Biochem; 2011 Apr 31; 27(5):479-86. PubMed ID: 21691065
    [Abstract] [Full Text] [Related]

  • 31. Apoptosis, coronary arterial remodeling, and myocardial infarction after nitric oxide inhibition in SHR.
    Ono Y, Ono H, Matsuoka H, Fujimori T, Frohlich ED.
    Hypertension; 1999 Oct 31; 34(4 Pt 1):609-16. PubMed ID: 10523335
    [Abstract] [Full Text] [Related]

  • 32. Antihypertensive agents prevent nephrosclerosis and left ventricular hypertrophy induced in rats by prolonged inhibition of nitric oxide synthesis.
    Akuzawa N, Nakamura T, Kurashina T, Saito Y, Hoshino J, Sakamoto H, Sumino H, Ono Z, Nagai R.
    Am J Hypertens; 1998 Jun 31; 11(6 Pt 1):697-707. PubMed ID: 9657629
    [Abstract] [Full Text] [Related]

  • 33. Differential effects of T- and L-type calcium antagonists on glomerular dynamics in spontaneously hypertensive rats.
    Nakamura Y, Ono H, Frohlich ED.
    Hypertension; 1999 Aug 31; 34(2):273-8. PubMed ID: 10454453
    [Abstract] [Full Text] [Related]

  • 34. TCV-116 stimulates eNOS and caveolin-1 expression and improves coronary microvascular remodeling in normotensive and angiotensin II-induced hypertensive rats.
    Kobayashi N, Mori Y, Nakano S, Tsubokou Y, Kobayashi T, Shirataki H, Matsuoka H.
    Atherosclerosis; 2001 Oct 31; 158(2):359-68. PubMed ID: 11583714
    [Abstract] [Full Text] [Related]

  • 35. Hydrogen sulfide defends against the cardiovascular risk of Nw-nitro-L-argininemethyl ester-induced hypertension in rats via the nitric oxide/endothelial nitric oxide synthase pathway.
    Ji W, Liu S, Dai J, Yang T, Jiang X, Duan X, Wu Y.
    Chin Med J (Engl); 2014 Oct 31; 127(21):3751-7. PubMed ID: 25382331
    [Abstract] [Full Text] [Related]

  • 36. Discoordinate re-expression of cardiac fetal genes in N(omega)-nitro-L-arginine methyl ester (L-NAME) hypertension.
    Zhang Y, Carreras D, de Bold AJ.
    Cardiovasc Res; 2003 Jan 31; 57(1):158-67. PubMed ID: 12504825
    [Abstract] [Full Text] [Related]

  • 37. Asiatic acid reduces blood pressure by enhancing nitric oxide bioavailability with modulation of eNOS and p47phox expression in L-NAME-induced hypertensive rats.
    Bunbupha S, Pakdeechote P, Kukongviriyapan U, Prachaney P, Kukongviriyapan V.
    Phytother Res; 2014 Oct 31; 28(10):1506-12. PubMed ID: 24723332
    [Abstract] [Full Text] [Related]

  • 38. Ventricular hypertrophy and arterial hemodynamics following deprivation of nitric oxide in rats.
    Hu CT, Chang HR, Hsu YH, Liu CJ, Chen HI.
    Life Sci; 2005 Nov 26; 78(2):164-73. PubMed ID: 16125730
    [Abstract] [Full Text] [Related]

  • 39. Paradoxical release of nitric oxide by an L-type calcium channel antagonist, the R+ enantiomer of amlodipine.
    Zhang XP, Loke KE, Mital S, Chahwala S, Hintze TH.
    J Cardiovasc Pharmacol; 2002 Feb 26; 39(2):208-14. PubMed ID: 11791006
    [Abstract] [Full Text] [Related]

  • 40. Chronic inhibition of nitric-oxide synthase potentiates endothelium-dependent contractions in the rat aorta by augmenting the expression of cyclooxygenase-2.
    Qu C, Leung SW, Vanhoutte PM, Man RY.
    J Pharmacol Exp Ther; 2010 Aug 26; 334(2):373-80. PubMed ID: 20444882
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.